O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)

@article{Ross2003O150AP,
  title={O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)},
  author={H. Ross and C. Rudin and R. Figlin and L. Hart and M. Rarick and A. D. Jacobs and L. Grove and A. Sandler and C. Siegall and A. Sing},
  journal={Lung Cancer},
  year={2003},
  volume={41}
}
  • H. Ross, C. Rudin, +7 authors A. Sing
  • Published 2003
  • Medicine
  • Lung Cancer